Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

An Phase 1 Study to Evaluate the Pharmacokinetic (PK) Profile of FDL169 New Formulations in Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03424252
Recruitment Status : Completed
First Posted : February 6, 2018
Last Update Posted : November 2, 2018
Information provided by (Responsible Party):
Flatley Discovery Lab LLC

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 15, 2018
Actual Study Completion Date : January 15, 2018